Symbol: |
TRIP13
|
Description: |
thyroid hormone receptor interactor 13 [Source:HGNC Symbol;Acc:12307]
|
Location: |
Chr5:892758-919472[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:132
Gene |
Compound |
Gen_sig |
Exp_pattern |
TRIP13 |
NSC 112789 |
0.013 |
Up |
TRIP13 |
NSC 116878 |
0.004 |
Down |
TRIP13 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) |
0.041 |
Down |
TRIP13 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.007 |
Down |
TRIP13 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.021 |
Down |
TRIP13 |
TZT |
0.008 |
Down |
TRIP13 |
Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- |
0.027 |
Down |
TRIP13 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.003 |
Down |
TRIP13 |
NSC 175296 |
0.044 |
Down |
TRIP13 |
9-METHOXYCAMPTOTHECIN |
0.007 |
Down |
TRIP13 |
1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- |
0.028 |
Down |
TRIP13 |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.013 |
Down |
TRIP13 |
2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- |
0.044 |
Down |
TRIP13 |
6-Benzylthioinosine |
0.042 |
Down |
TRIP13 |
NSC 270927 |
0.004 |
Down |
Expression pattern: Sensitivity / Resistance
Total:9 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:15
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:43
Total:3 Current:1
[First] [Prev]  Next Last 
|